Blast These People (China)
The Market Ticker - Commentary on The Capital Markets
Logging in or registering will improve your experience here
Main Navigation
Full-Text Search & Archives

Legal Disclaimer

The content on this site is provided without any warranty, express or implied. All opinions expressed on this site are those of the author and may contain errors or omissions.


The author may have a position in any company or security mentioned herein. Actions you undertake as a consequence of any analysis, opinion or advertisement on this site are your sole responsibility.

Market charts, when present, used with permission of TD Ameritrade/ThinkOrSwim Inc. Neither TD Ameritrade or ThinkOrSwim have reviewed, approved or disapproved any content herein.

The Market Ticker content may be sent unmodified to lawmakers via print or electronic means or excerpted online for non-commercial purposes provided full attribution is given and the original article source is linked to. Please contact Karl Denninger for reprint permission in other media, to republish full articles, or for any commercial use (which includes any site where advertising is displayed.)

Submissions or tips on matters of economic or political interest may be sent "over the transom" to The Editor at any time. To be considered for publication your submission must include full and correct contact information and be related to an economic or political matter of the day. All submissions become the property of The Market Ticker.

Considering sending spam? Read this first.

2019-09-20 07:00 by Karl Denninger
in Editorial , 119 references Ignore this thread
Blast These People (China)
[Comments enabled]

No, really?

There are two sources of supply. Mexican cartels and packages shipped direct from China, where it is produced in a huge and under-regulated chemical sector. A Senate investigation last year found massive quantities of fentanyl pouring in from China through the Postal Service. The report largely blamed dated technology that left customs inspectors sifting through packages manually looking for “the proverbial needle in a haystack.” The Postal Service wrote in a statement to The Associated Press that it is working hard with its international counterparts to close those loopholes, and is improving its technology to intercept fentanyl shipments.

Why do we have so-called "free trade" with either of these nations?

The answer to this problem is simple: Stop it or we embargo your ass and, furthermore, we're assessing you for all the deaths you have caused at a million bucks each, payable now or the border is closed and every single person and item trying to come in to the United States is refused.

What happens after the raw material gets here is where the problem is -- there's no quality control in a basement pill mill and due to the extremely high potency of fentanyl you literally are rolling the dice with death each time you use one of those counterfeit pills.  You have no idea how much active ingredient is in there -- it could easily vary by more than 10x from one to the next which plenty enough to either not have the desired effect or kill you dead instantly.

This is the problem with illegal supply of drugs exactly as it is with the vape situation; black-market and other "unregulated" entities that don't give a flying **** about consistency and have zero accountability, whether a criminal enterprise (as in this case) or otherwise, produce things intended for human consumption that are not as described on the label.  The result is massive harm -- not necessarily intentional harm, but grossly negligent harm.

There are plenty of ways to stop this and it begins with the sources for those unlawful acts being interdicted and shut down and, where state actors or quasi-state actors are involved, such as the Chinese government and the Mexican government with their drug lords it means slamming closed the border gates until and unless the governments involved cut that crap out, whether it be active involvement or their obvious and willful refusal to put a stop to it.

View with responses (opens new window)